Elena Cellini1, Aglaia Vignoli2, Tiziana Pisano1, Melania Falchi1, Anna Molinaro3, Patrizia Accorsi4, Alessia Bontacchio4, Lorenzo Pinelli5, Lucio Giordano4, Renzo Guerrini1. 1. Pediatric Neurology Unit, Children's Hospital A Meyer -University of Florence, Florence, Italy. 2. Department of Health Sciences, Epilepsy Center, San Paolo Hospital, University of Milan, Milan, Italy. 3. School in Reproductive and Developmental Science, University of Trieste and University of Brescia, Brescia, Italy. 4. Child Neurology and Psychiatry Unit, Spedali Civili, Brescia, Italy. 5. Neuroradiology Unit, Spedali Civili, Brescia, Italy.
Abstract
AIM: Forkhead Box G1 (FOXG1) syndrome is a developmental encephalopathy characterized by postnatal microcephaly, structural brain abnormalities, facial dysmorphisms, severe delay with absent language, defective social interactions, and epilepsy. Abnormal movements in FOXG1 syndrome have often been mentioned but not characterized. METHOD: We clinically assessed and analysed video recordings of eight patients with different mutations or copy number variations affecting the FOXG1 gene and describe the peculiar pattern of the associated movement disorder. RESULTS: The age of the patients in the study ranged from 2 to 17 years old (six females, two males). They had severe epilepsy and exhibited a complex motor disorder including various combinations of dyskinetic and hyperkinetic movements featuring dystonia, chorea, and athetosis. The onset of the movement disorder was apparent within the first year of life, reached its maximum expression within months, and then remained stable. INTERPRETATION: A hyperkinetic-dyskinetic movement disorder emerges as a distinctive feature of the FOXG1-related phenotype. FOXG1 syndrome is as an epileptic-dyskinetic encephalopathy whose clinical presentation bears similarities with ARX- and STXBP1-gene related encephalopathies.
AIM: Forkhead Box G1 (FOXG1) syndrome is a developmental encephalopathy characterized by postnatal microcephaly, structural brain abnormalities, facial dysmorphisms, severe delay with absent language, defective social interactions, and epilepsy. Abnormal movements in FOXG1 syndrome have often been mentioned but not characterized. METHOD: We clinically assessed and analysed video recordings of eight patients with different mutations or copy number variations affecting the FOXG1 gene and describe the peculiar pattern of the associated movement disorder. RESULTS: The age of the patients in the study ranged from 2 to 17 years old (six females, two males). They had severe epilepsy and exhibited a complex motor disorder including various combinations of dyskinetic and hyperkinetic movements featuring dystonia, chorea, and athetosis. The onset of the movement disorder was apparent within the first year of life, reached its maximum expression within months, and then remained stable. INTERPRETATION: A hyperkinetic-dyskinetic movement disorder emerges as a distinctive feature of the FOXG1-related phenotype. FOXG1 syndrome is as an epileptic-dyskinetic encephalopathy whose clinical presentation bears similarities with ARX- and STXBP1-gene related encephalopathies.
Authors: Steffen Syrbe; Frederike L Harms; Elena Parrini; Martino Montomoli; Ulrike Mütze; Katherine L Helbig; Tilman Polster; Beate Albrecht; Ulrich Bernbeck; Ellen van Binsbergen; Saskia Biskup; Lydie Burglen; Jonas Denecke; Bénédicte Heron; Henrike O Heyne; Georg F Hoffmann; Frauke Hornemann; Takeshi Matsushige; Ryuki Matsuura; Mitsuhiro Kato; G Christoph Korenke; Alma Kuechler; Constanze Lämmer; Andreas Merkenschlager; Cyril Mignot; Susanne Ruf; Mitsuko Nakashima; Hirotomo Saitsu; Hannah Stamberger; Tiziana Pisano; Jun Tohyama; Sarah Weckhuysen; Wendy Werckx; Julia Wickert; Francesco Mari; Nienke E Verbeek; Rikke S Møller; Bobby Koeleman; Naomichi Matsumoto; William B Dobyns; Domenica Battaglia; Johannes R Lemke; Kerstin Kutsche; Renzo Guerrini Journal: Brain Date: 2017-09-01 Impact factor: 13.501
Authors: Diana Mitter; Milka Pringsheim; Marc Kaulisch; Kim Sarah Plümacher; Simone Schröder; Rita Warthemann; Rami Abou Jamra; Martina Baethmann; Thomas Bast; Hans-Martin Büttel; Julie S Cohen; Elizabeth Conover; Carolina Courage; Angelika Eger; Ali Fatemi; Theresa A Grebe; Natalie S Hauser; Wolfram Heinritz; Katherine L Helbig; Marion Heruth; Dagmar Huhle; Karen Höft; Stephanie Karch; Gerhard Kluger; G Christoph Korenke; Johannes R Lemke; Richard E Lutz; Steffi Patzer; Isabelle Prehl; Konstanze Hoertnagel; Keri Ramsey; Tina Rating; Angelika Rieß; Luis Rohena; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Barbara Zoll; Dörthe Malzahn; Birgit Zirn; Knut Brockmann Journal: Genet Med Date: 2017-06-29 Impact factor: 8.822
Authors: H Fryssira; E Tsoutsou; S Psoni; S Amenta; T Liehr; E Anastasakis; Ch Skentou; A Ntouflia; I Papoulidis; E Manolakos; N Chaliasos Journal: Mol Cytogenet Date: 2016-08-02 Impact factor: 2.009
Authors: Marianna Madeo; Michelle Stewart; Yuyang Sun; Nadia Sahir; Sarah Wiethoff; Indra Chandrasekar; Anna Yarrow; Jill A Rosenfeld; Yaping Yang; Dawn Cordeiro; Elizabeth M McCormick; Colleen C Muraresku; Tyler N Jepperson; Lauren J McBeth; Mohammed Zain Seidahmed; Heba Y El Khashab; Muddathir Hamad; Hamid Azzedine; Karl Clark; Silvia Corrochano; Sara Wells; Mariet W Elting; Marjan M Weiss; Sabrina Burn; Angela Myers; Megan Landsverk; Patricia L Crotwell; Quinten Waisfisz; Nicole I Wolf; Patrick M Nolan; Sergio Padilla-Lopez; Henry Houlden; Richard Lifton; Shrikant Mane; Brij B Singh; Marni J Falk; Saadet Mercimek-Mahmutoglu; Kaya Bilguvar; Mustafa A Salih; Abraham Acevedo-Arozena; Michael C Kruer Journal: Am J Hum Genet Date: 2016-05-26 Impact factor: 11.025
Authors: Apostolos Papandreou; Ruth B Schneider; Erika F Augustine; Joanne Ng; Kshitij Mankad; Esther Meyer; Amy McTague; Adeline Ngoh; Cheryl Hemingway; Robert Robinson; Sophia M Varadkar; Maria Kinali; Vincenzo Salpietro; Margaret C O'Driscoll; S Nigel Basheer; Richard I Webster; Shekeeb S Mohammad; Shpresa Pula; Marian McGowan; Natalie Trump; Lucy Jenkins; Frances Elmslie; Richard H Scott; Jane A Hurst; Belen Perez-Duenas; Alexander R Paciorkowski; Manju A Kurian Journal: Neurology Date: 2016-03-30 Impact factor: 9.910